Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG)
- PMID: 34183790
- DOI: 10.1038/s41436-021-01247-1
Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG)
Erratum in
- 
  
  Correction to: Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2021 Nov;23(11):2226. doi: 10.1038/s41436-021-01275-x. Genet Med. 2021. PMID: 34302125 No abstract available.
References
Reference
- 
    - ACMG Board of Directors. Direct-to-consumer genetic testing: a revised position statement of the American College of Medical Genetics and Genomics. Genet. Med. 2016;18:207–8. - DOI
 
MeSH terms
LinkOut - more resources
- Full Text Sources
 
        